Volex (AIM: VLX) upgrades FY2026 revenue to at least $1.22bn as AI data centre demand doubles and board eyes Main Market move
Can inhaled nintedanib improve tolerability and adherence in IPF treatment, according to Avalyn Pharma Inc.?
Read More 3 minute read Pharma Industry News Dr. Reddy’s Laboratories gets DCGI nod for phase 3 trial of Sputnik V Covid-19 vaccine Dr. Reddy’s Laboratories has recently received approval from the Drugs Control General of India (DCGI) to proceed with… bypharmanewsdailyJanuary 16, 2021
